Insmed
NASDAQ: INSMIncorporated in Virginia · 6 known investors
Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
Investors · 6
Acquisitions · 1
Early investors' stakes continue via these dealsAdrestia Therapeutics
Early-stage drug discovery platform, acquired by Insmed
In the news
Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · Jul 2026Frequently asked questions
- What does Insmed do?
- Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.
- Who are Insmed's investors?
- Insmed's investors include Bessemer Venture Partners, F-Prime Capital, Foresite Capital, OrbiMed, Prospect Venture Partners, NVIDIA.